Archives for: July 17th, 2019

CORMEDIX PRESENTS AT FDA PUBLIC MEETING ON THE LIMITED POPULATION PATHWAY FOR ANTIBACTERIAL AND ANTIFUNGAL DRUGS

Written by Sam Nelson on July 17, 2019

Berkeley Heights, NJ – July 17, 2019 – CorMedix Inc….

CORMEDIX RECEIVES ENCOURAGING FDA FEEDBACK ON NEUTROLIN® LOCK-IT-100 DATA

Written by Sam Nelson on July 9, 2019

Company Completes Phase 3 of Clinical Development Berkeley Heights, NJ…

CORMEDIX ANNOUNCES PUBLICATION OF TAUROLIDINE PRE-CLINICAL ONCOLOGY DATA IN “INVESTIGATIONAL NEW DRUGS” JOURNAL

Written by Sam Nelson on July 8, 2019

Berkeley Heights, NJ – July 8, 2019 – CorMedix Inc. (NYSE…